Arcus Biosciences Inc
NYSE:RCUS
Arcus Biosciences Inc
Other Equity
Arcus Biosciences Inc
Other Equity Peer Comparison
Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors
Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Arcus Biosciences Inc
NYSE:RCUS
|
Other Equity
-$1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Other Equity
-$2.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-19%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Equity
$69m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Equity
-$190m
|
CAGR 3-Years
39%
|
CAGR 5-Years
14%
|
CAGR 10-Years
-4%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Equity
$27.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Equity
-$77.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Arcus Biosciences Inc's Other Equity?
Other Equity
-1m
USD
Based on the financial report for Mar 31, 2024, Arcus Biosciences Inc's Other Equity amounts to -1m USD.
What is Arcus Biosciences Inc's Other Equity growth rate?
Other Equity CAGR 1Y
75%
Over the last year, the Other Equity growth was 75%.